Citation Impact
Citing Papers
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome
2008 StandoutNobel
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
2009 StandoutScience
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
2007
The CCR5 and CXCR4 Coreceptors—Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection
2004
IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis
2010
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
Leishmaniasis
2018 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
IL-15: targeting CD8+T cells for immunotherapy
2005
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Mutagenicity, toxicity and repair of DNA base damage induced by oxidation
2003
Modeling Plasma Virus Concentration during Primary HIV Infection
2000
Why Most Published Research Findings Are False
2005 Standout
T cell exhaustion
2011 Standout
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Grade 4 Events Are as Important as AIDS Events in the Era of HAART
2003
Microbial translocation, immune activation, and HIV disease
2012
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection
2002
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Immune Restoration With Antiretroviral Therapies
2000
Impact of Suppression of Viral Replication by Highly Active Antiretroviral Therapy on Immune Function and Phenotype in Chronic HIV-1 Infection
2002
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
2011
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
2015 StandoutNobel
Psoriasis
2015 Standout
C → T mutagenesis and γ‐radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases
2005 StandoutNobel
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
The end of AIDS: HIV infection as a chronic disease
2013 Standout
T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy
2003
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Sickle-cell disease
2010 Standout
Liver transplantation in patients with HIV infection
2004
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
2011
Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection
2004
Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
2011
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
2001
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients
2011
De novo T-cell generation in patients at different ages and stages of HIV-1 disease
2004
PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
2013
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Normalization of Immune Activation in Lymphoid Tissue Following Highly Active Antiretroviral Therapy
2000
HIV fusion and its inhibition
2001
The Hallmarks of Aging
2013 Standout
The CD4 lymphocyte count and risk of clinical progression
2006
Infection in Solid-Organ Transplant Recipients
2007 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Molecular and cellular insights into T cell exhaustion
2015 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Leishmania Induces Survival, Proliferation and Elevated Cellular dNTP Levels in Human Monocytes Promoting Acceleration of HIV Co-Infection
2012
CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater
2007
Mycobacterium avium Infection and Immune Restoration Disease After Highly Active Antiretroviral Therapy in a Patient with HIV and Normal CD4+ Counts
2001
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA
2016
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
CD4+ T-Lymphocyte Nadir and the Effect of Highly Active Antiretroviral Therapy on Phenotypic and Functional Immune Restoration in HIV-1 Infection
2002
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis
2004
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Central Memory CD4+ T Cell Responses in Chronic HIV Infection Are Not Restored by Antiretroviral Therapy
2004
IL-7 Stimulates T Cell Renewal Without Increasing Viral Replication in Simian Immunodeficiency Virus-Infected Macaques
2003 StandoutNobel
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
2004
Normalization of Immune Activation in Lymphoid Tissue Following Highly Active Antiretroviral Therapy
2000
Defective Human Immunodeficiency Virus-Specific CD8 + T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy
2009
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
2010 Standout
Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
2012 StandoutNobel
HIV Infection, Inflammation, Immunosenescence, and Aging
2010
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
2014 Standout
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
Interleukin-7 restores immunity in athymic T-cell–depleted hosts
2001
Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4+CD8−CD3+ thymocytes through sustained induction of Bcl-2
2001 StandoutNobel
IL-7 Abrogates Suppressive Activity of Human CD4+CD25+FOXP3+ Regulatory T Cells and Allows Expansion of Alloreactive and Autoreactive T Cells
2012
Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution
2012
Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
2005
Review of solid-organ transplantation in HIV-infected patients
2003
Photochemical Deamination and Demethylation of 5-Methylcytosine
1996
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Emerging Nanotechnology Approaches for HIV/AIDS Treatment and Prevention
2010
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Positive Regulation of CXCR4 Expression and Signaling by Interleukin-7 in CD4+Mature Thymocytes Correlates with Their Capacity To Favor Human Immunodeficiency X4 Virus Replication
2003 StandoutNobel
HIV VACCINES
2005
Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease
2008
IL-15: targeting CD8+ T cells for immunotherapy
2005
Consensus Guidelines for the Management of Plaque Psoriasis
2012
Prospects for the Future
2002 StandoutScienceNobel
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
2004
Works of Lawrence Fox being referenced
Short Communication : Effect of Etanercept (Enbrel) on Interleukin 6, Tumor Necrosis Factor α , and Markers of Immune Activation in HIV-Infected Subjects Receiving Interleukin 2
2002
Activity, Safety, and Immunological Effects of Hydroxyurea Added to Didanosine in Antiretroviral-Naive and Experienced HIV Type 1-Infected Subjects: A Randomized, Placebo-Controlled Trial, ACTG 307
2004
Thalidomide in Low Intermittent Doses Does Not Prevent Recurrence of Human Immunodeficiency Virus–Associated Aphthous Ulcers
2001
Characterization of Viral Dynamics in Human Immunodeficiency Virus Type 1–Infected Patients Treated with Combination Antiretroviral Therapy: Relationships to Host Factors, Cellular Restoration, and Virologic End Points
1999
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen
2000
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy
2009
Age‐Related Immune Dysfunction in Health and in Human Immunodeficiency Virus (HIV) Disease: Association of Age and HIV Infection with Naive CD8+Cell Depletion, Reduced Expression of CD28 on CD8+Cells, and Reduced Thymic Volumes
2003
A Study of the Immunology, Virology, and Safety of Prednisone in HIV-1–Infected Subjects with CD4 Cell Counts of 200 to 700 mm−3
2003
Granulocyte‐Macrophage Colony‐Stimulating Factor Induces Modest Increases in Plasma Human Immunodeficiency Virus (HIV) Type 1 RNA Levels and CD4+Lymphocyte Counts in Patients with Uncontrolled HIV Infection
2003
Interleukin‐2 Increases CD4+Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s
2003
Immune Reconstitution in the First Year of Potent Antiretroviral Therapy and Its Relationship to Virologic Response
2000
Evidence That Intermittent Structured Treatment Interruption, but Not Immunization with ALVAC‐HIV vCP1452, Promotes Host Control of HIV Replication: The Results of AIDS Clinical Trials Group 5068
2006
Limited immune restoration after 3 years’ suppression of HIV-1 replication in patients with moderately advanced disease
2002
A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)
2006
In Vivo Antagonism with Zidovudine plus Stavudine Combination Therapy
2000
Placebo-Controlled Trial of Cyclosporin-A in HIV-1 Disease: Implications for Solid Organ Transplantation
2002
Randomized, Open-Label Study of the Impact of Two Doses of Subcutaneous Recombinant Interleukin-2 on Viral Burden in Patients With HIV-1 Infection and CD4+ Cell Counts of ≥300/mm3: CPCRA 059
2002
Incorporation of 5-Substituted Analogs of Deoxycytidine into DNA of Herpes Simplex Virus-Infected or -Transformed Cells Without Deamination to the Thymidine Analog
1983
IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection
2009